Results 271 to 280 of about 207,670 (383)

A Case of Anti‐TNFα Therapies Induced Lupus Panniculitis Successfully Improved With a JAK Inhibitor (Baricitinib)

open access: yesJEADV Clinical Practice, EarlyView.
ABSTRACT Lupus erythematosus panniculitis (LEP) is a rare variant of cutaneous lupus erythematosus (1%–3% of CLE). There are two case reports to date in the literature of LEP potentially triggered by anti‐TNF‐α therapies. Clinically, it is characterised by tender, erythematous subcutaneous indurated nodules or plaques on fatty body areas.
Cristina Grechin   +4 more
wiley   +1 more source

Identifying Cellular Immunodeficiency Through a Persistent Herpetic Whitlow

open access: yesJEADV Clinical Practice, EarlyView.
ABSTRACT Cutaneous infections caused by HSV are common, with the oral and genital mucosa being most frequently affected (1, 2). In individuals with immunodeficiency, HSV‐2 caused skin lesions may appear severe and unusual, or occur simultaneously with other skin diseases (3).
Chiara L. Blomen   +4 more
wiley   +1 more source

Treatment of Pyoderma Gangrenosum With Bimekizumab

open access: yesJEADV Clinical Practice, EarlyView.
ABSTRACT Pyoderma gangrenosum (PG) is an inflammatory neutrophilic dermatosis with no FDA‐approved treatments. Current therapies, including corticosteroids and immunomodulators, often show limited efficacy and nonspecific, conferring to higher risk of adverse events.
Kareena S. Garg   +2 more
wiley   +1 more source

A longitudinal analysis of pathogen shedding patterns in confiscated eastern box turtles

open access: yesThe Journal of Wildlife Management, EarlyView.
Seventeen confiscated eastern box turtles were sampled for 4 pathogens monthly for a year to determine optimal sampling strategies and variation in pathogen shedding patterns. Observed prevalence values were within 10% of unbiased prevalence values, but the probability of detecting pathogens in an infected turtle during a given month was generally low,
Maris J. Daleo   +9 more
wiley   +1 more source

The T-cell response to SARS-CoV- 2 vaccination persists beyond six months in rheumatoid arthritis patients treated with rituximab. [PDF]

open access: yesArthritis Res Ther
Marin J   +6 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy